Ohsu Cdrc
Portland, Oregon, 97239, United States
NCT Number: NCT04861740
Autism Access Link for Early Referral and Treatment [ALERT], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process. We hypothesize that Autism ALERT will have strong acceptability and high rates of use among primary care providers as well as among diverse low-income patients of children at risk for ASD, and that we will see higher rates of child ASD educational evaluations within six months, and shorter time between referral and ASD treatment, compared with our control.
Looking for future studies?
Notify Me12 month–54 month
All sexes
Interventional
Not applicable
Portland, Oregon, 97239, United States
Though significant research effort has focused on autism spectrum disorder (ASD) screening, less attention has been devoted to optimizing follow-up of children who are subsequently identified as at-risk. Despite increases in ASD screening rates, many children with ASD wait years between when autism is suspected in the primary care setting and when definitive diagnosis and treatment begin. Delayed and missed diagnoses are particularly problematic for low-income and racial/ethnic minority children in the US, who experience higher rates of these adverse outcomes. In this project, we propose to pilot test Autism Access Link to Early Referral and Treatment (Autism ALERT), a statewide monitoring and case management program to accelerate access to ASD diagnosis and treatment among children with suspected ASD the primary care setting. The system will reduce the time between identification of suspected ASD in the primary care setting and establishment of ASD diagnosis and treatment services, by reducing family barriers to care, decreasing primary care provider burdens, and simplifying referral processes. The program will be available to any Oregon child age 12-54 months, regardless of health system or payor type. Autism ALERT will become part of the Help Me Grow national network, which gives it potential for statewide and national spread. In this proposed research, we will pilot test Autism ALERT by comparing it to an existing ASD screening intervention in 6 Oregon primary care practices. Primary goals of this pilot project are to assess feasibility and acceptability of Autism ALERT for primary care providers and families, to test the mechanism of action of Autism ALERT, to pilot test efficacy in reducing time to autism diagnosis and treatment, and to test fidelity of protocol implementation. If successful, this project will be expanded into an implementation/effectiveness R01 in which the program will be tested throughout the state of Oregon. In the long term, this research will result in a sustainable, evidence-based statewide and ultimately national monitoring system children with suspected ASD.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
child's primary care provider suspects the child has ASD, child is patient at one of the study clinics, child age 12 to 54 months, family speaks English or Spanish, no prior ASD medical diagnosis or ASD diagnostic evaluation
Exclusion criteria
Previous diagnosis of ASD or prior diagnostic evaluation for ASD.
Autism Access Link for Early Referral and Treatment [ALERT], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process.
Autism screening intervention only.
Other names: START Autism
Time frame: At enrollment and study end (~9 months after enrollment)
2 separate provider survey measures
Time frame: At enrollment and 6 months after enrollment
Parent Survey - Parenting Stress Index
Time frame: At enrollment and 6 months after enrollment
Questionnaire on Resources and stress - Short Form
Time frame: At enrollment and 6 months after enrollment
Parent Survey - Family Empowerment Scale, Family Subscale
Time frame: At enrollment and 6 months after enrollment
Parent Survey - Items from National Survey of Children's Health, Medical Home item set
Time frame: 6 months after enrollment - Autism ALERT + Screening arm only
Parent Survey items - Satisfaction with Interpersonal Relationship with Navigator (PSN-I), Client Satisfaction Questionnaire - 8
Time frame: 6 months after enrollment
Administrative data - Oregon Early Intervention/Early Childhood Special Ed (EI/ECSE) database
Time frame: measured 9 months after enrollment
Administrative data - Oregon EI/ECSE database
Time frame: At enrollment and 9 months after enrollment
5-item survey measure
Time frame: At enrollment and at study end (~9 months after enrollment)
1-item survey measure
Time frame: At enrollment and at study end (~9 months after enrollment)
Provider survey item
Time frame: measured 9 months after enrollment
Administrative data - Oregon EI/ECSE database
Time frame: measured 9 months after enrollment
Administrative data - Oregon EI/ECSE database
Time frame: measured 9 months after enrollment
Administrative data - Oregon EI/ECSE database
Time frame: measured 9 months after enrollment
Administrative data - Oregon EI/ECSE database
Time frame: Measured 1 year after study enrollment
Administrative data - Medicaid claims
Time frame: Measured 1 year after study enrollment
Administrative data - Medicaid claims
Oregon Health and Science University
Other
Acronym: Autism ALERT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06352372
Autism Spectrum Disorder, Autistic Disorder
Phoenix, Arizona, United States
View Trial DetailsNCT07277101
Autism Spectrum Disorder, Autistic Disorder
Shanghai, China
View Trial DetailsNCT06361147
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Heraklion, Crete, Greece
View Trial DetailsNCT06508515
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Seattle, Washington, United States
View Trial Details